Virbac SACA

Virbac : Declaration of the number of shares and voting rights 12/2025

09 1 2026 12:05:59 提供 Nasdaq GlobeNewswire

VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm

16 12 2025 03:53:22 提供 Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 11/2025

08 12 2025 04:13:13 提供 Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 10/2025

07 11 2025 09:39:51 提供 Nasdaq GlobeNewswire

VIRBAC Announces Third Quarter 2025 Sales

16 10 2025 11:45:00 提供 Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 09/2025

03 10 2025 10:55:55 提供 Nasdaq GlobeNewswire

Virbac: 2025 Half-year results

12 9 2025 11:45:00 提供 Nasdaq GlobeNewswire

Virbac : Half-yearly financial report 2025

12 9 2025 11:30:00 提供 Nasdaq GlobeNewswire

Virbac : Public release of the Half-Year Financial Report at 30 June 2025.

12 9 2025 11:30:00 提供 Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 08/2025

05 9 2025 08:45:19 提供 Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 07/2025

05 9 2025 08:40:35 提供 Nasdaq GlobeNewswire

Virbac:: Paul Martingell's compensation terms

18 8 2025 03:30:00 提供 Nasdaq GlobeNewswire

Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation

16 7 2025 11:45:00 提供 Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 06/2025

04 7 2025 06:04:16 提供 Nasdaq GlobeNewswire

VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025

19 6 2025 02:30:00 提供 Nasdaq GlobeNewswire

Virbac : Declaration of the number of share and voting rights 05/2025

10 6 2025 03:59:29 提供 Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 04/2025

07 5 2025 10:27:25 提供 Nasdaq GlobeNewswire

Virbac : Public release of Virbac Annual Report at 31 December 2024

28 4 2025 13:00:00 提供 Nasdaq GlobeNewswire

Virbac: In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope

15 4 2025 11:45:00 提供 Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 03/2025

09 4 2025 11:30:02 提供 Nasdaq GlobeNewswire